Download PDF

Other users also viewed these articles

Evaluation of remission in ulcerative colitis: Relationship between clinical, endoscopic, and histological markers as predictors of relapse Francisca Carvajal; Karin Herrera; Paulina Núñez; Lilian Flores; Andrea Córdova; Gonzalo Pizarro; Pamela San Martín; Luis Contreras; Rodrigo Quera;
Gastroenterol Hepatol. 2025;48:
Mesalazine dose modification based on faecal calprotectin levels in patients with ulcerative colitis in clinical remission Gisela Piñero; Míriam Mañosa; Margalida Calafat; Eva Vayreda; Fiorella Cañete; Maria Puig; Eugeni Domènech;
Gastroenterol Hepatol. 2024;47:612-9
Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease Francisco Guilherme Cancela Penna; Rodrigo Macedo Rosa; Fernando H. Pereira; Pedro Ferrari Sales Cunha; Stella Cristina S. Sousa; Teresa Cristina A. Ferrari; Carlos Cara; Maria de Lourdes A. Ferrari;
Gastroenterol Hepatol. 2021;44:87-95